| Filed On | Filing |
|---|---|
| 29 Oct 2026 | 10-Q |
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Date of Report (Date of earliest event reported): October 29, 2026 |
| 19 Oct 2026 |
Form 4: Cagnoni Pablo J, President, Global Head of R&D
Received 2,642 shares by exercise or conversion ($174K) · Sold 2,642 shares ($298K) |
| 15 Oct 2026 | 144 |
| 05 Oct 2026 |
Form 4: Heeson Lee, EVP, Head of Incyte Intl
Gave up 463 shares to cover exercise price or tax ($54.2K) |
| 02 Oct 2026 |
Form 4: Clancy Paul J, Director
Received 203 shares as a grant or award ($24.6K) |
| 02 Oct 2026 |
Form 4: Baker Bros. Advisors Lp, Director and 5 others
Received 644 shares as a grant or award |
| 02 Oct 2026 |
Form 4: Harrigan Edmund, Director
Received 206 shares as a grant or award ($25K) |
| 24 Sep 2026 |
Form 4: Gardner David H, EVP, Chief Strategy Officer
Gave up 920 shares to cover exercise price or tax ($117K) |
| 17 Sep 2026 |
Form 4: Cagnoni Pablo J, President, Global Head of R&D
Received 23,218 shares by exercise or conversion ($1.54M) · Sold 23,218 shares ($2.8M) |
| 15 Sep 2026 | 144 |
| 31 Aug 2026 | 8-K: Other Events |
| 27 Aug 2026 |
Form 4: Basi Ramitpal K, EVP, Human Resources
Gave up 504 shares to cover exercise price or tax ($65.4K) |
| 20 Aug 2026 |
Form 4: Cagnoni Pablo J, President, Global Head of R&D
Sold 10,801 shares ($1.36M) |
| 19 Aug 2026 | 144 |
| 14 Aug 2026 |
Form 4: Cagnoni Pablo J, President, Global Head of R&D
Sold 10,803 shares ($1.3M) |
| 12 Aug 2026 | 144 |
| 07 Aug 2026 |
Form 4: Cagnoni Pablo J, President, Global Head of R&D
Sold 10,640 shares ($1.31M) |
| 07 Aug 2026 |
Form 4: Mayes Patrick A, EVP & Chief Scientific Officer
Received 2,207 shares by exercise or conversion ($235K) · Sold 2,207 shares ($274K) |
| 05 Aug 2026 | 144 |
Loading...